- Home
- CORT vs WAL Comparison
CORT vs WAL Comparison
Compare CORT & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- WAL
- Stock Information
- Founded
- CORT 1998
- WAL 1994
- Country
- CORT United States
- WAL United States
- Employees
- CORT N/A
- WAL N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- WAL Major Banks
- Sector
- CORT Health Care
- WAL Finance
- Exchange
- CORT Nasdaq
- WAL Nasdaq
- Market Cap
- CORT 7.1B
- WAL 7.8B
- IPO Year
- CORT N/A
- WAL 2005
- Fundamental
- Price
- CORT $70.84
- WAL $79.87
- Analyst Decision
- CORT Strong Buy
- WAL Strong Buy
- Analyst Count
- CORT 4
- WAL 15
- Target Price
- CORT $142.00
- WAL $95.13
- AVG Volume (30 Days)
- CORT 1.3M
- WAL 1.0M
- Earning Date
- CORT 05-05-2025
- WAL 04-21-2025
- Dividend Yield
- CORT N/A
- WAL 1.90%
- EPS Growth
- CORT 8.36
- WAL 6.13
- EPS
- CORT 1.14
- WAL 7.28
- Revenue
- CORT $685,446,000.00
- WAL $3,049,400,000.00
- Revenue This Year
- CORT $35.85
- WAL $13.26
- Revenue Next Year
- CORT $35.22
- WAL $9.87
- P/E Ratio
- CORT $61.79
- WAL $11.00
- Revenue Growth
- CORT 30.93
- WAL 11.37
- 52 Week Low
- CORT $25.35
- WAL $56.70
- 52 Week High
- CORT $117.33
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- CORT 51.25
- WAL 66.66
- Support Level
- CORT $69.33
- WAL $70.45
- Resistance Level
- CORT $73.36
- WAL $80.99
- Average True Range (ATR)
- CORT 3.36
- WAL 2.11
- MACD
- CORT -0.23
- WAL 1.42
- Stochastic Oscillator
- CORT 45.66
- WAL 91.44
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.